ViiV’s HIV therapy Triumeq shows efficacy in women
ViiV Healthcare’s Triumeq has come out on top in a late-stage study pitting its effectiveness in treating women with HIV against that of an atazanavir-based regimen.
Read More
Tag: atazanavir
Six new medicines put forward for EU nod
Six new medicines have cleared a key hurdle on the path to European approval after winning favour with regulatory advisors.
Read More
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
- eXmoor Pharma and UCL establish strategic cell and gene therapy collaboration
